Illinois Public Act 103-1064 amends Illinois Controlled Substances Act on chronic pain prescribing and Prescription Monitoring Program (PMP) confidentiality/access

Public Act 103-1064 (HB 5373) amends the Illinois Controlled Substances Act, including provisions affecting opioid/chronic pain prescribing and the Illinois Prescription Monitoring Program (ILPMP). The amendment states that ordering/prescribing/dispensing/administering/paying for controlled substances (including opioids) must not be predetermined by specific morphine milligram equivalent (MME) guidelines except as provided under federal law. It also tightens/clarifies conditions for release of confidential PMP data, requiring a written showing of a valid court order/subpoena or an administrative subpoena issued by IDFPR, and excludes 42 CFR Part 2–protected records/opioid treatment program confidential information from inter-agency sharing. Compliance teams should review controlled-substance prescribing policies, PMP access/request procedures, and data handling workflows to ensure subpoena/court-order gating and Part 2 segregation are implemented.